Dr. Richard Béliveau – Consultant

Richard Béliveau, Ph.D. in Biochemistry, is Scientific Director of the Chair in Prevention and Treatment of Cancer of the Université du Québec à Montréal.   He was Professor of Surgery and Physiology at Université de Montréal and held the Chair of Neurosurgery of the CHUM. He is an associate researcher at the Cancer Prevention Center …Lire la suite

Christian Marsolais

Dr.Christian Marsolais has over 25 years of experience in the research, development and commercialization of new drugs. He started his career in international pharmaceutical companies, including Sandoz, Biochem and Pfizer, where he held different positions from medical advisor to director clinical research and medical affairs. He was also appointed to the global oncology team at …Lire la suite

Jocelyn Lafond

Mr.Lafond has over 20 years of experience in the fields of corporate and securities laws.   Mr. Lafond holds a law degree from Université Laval and a Masters Degree in Law from the University of Toronto. He has been a member of the Barreau du Québec since 1992. Prior to joining Theratechnologies, Mr. Lafond was …Lire la suite

Philippe Dubuc

Mr.Dubuc brings more than 25 years of experience in investment banking in the healthcare sector and in management.   He started his career as a management consultant at Groupe Secor, a well-known Quebec-based consulting firm which is now part of KPMG. He then served as Managing Director, Investment Banking at National Bank Financial. In this …Lire la suite

Marie-Noël Colussi

Ms.Marie-Noël Colussi is a graduate of Université du Québec à Montréal in business administration.   Prior to joining Theratechnologies, Ms. Colussi worked for eight years with KPMG, a major accounting firm. Ms. Colussi has acquired sound experience in accounting, auditing, control and taxation, particularly in R&D. She joined Theratechnologies in March 1997, and prior to …Lire la suite

Denis Boucher

Mr. Boucher joined the Corporation in January, 2018 and brings more than 30 years of experience in communications, government affairs and crisis management.   Prior to joining Theratechnologies, Mr. Boucher practiced litigation and labour and employment law at a firm in the region of Montreal. He was previously a partner for 15 years Canada’s largest …Lire la suite

Sheila M. Frame

Ms. Frame is currently Vice President and Head Biopharmaceuticals, North America at Sandoz Inc. (a division of Novartis) in the United States.   Previously, she successively held the positions of Worldwide General Manager, Immunoscience, Worldwide Commercial Lead, Opdivo® new indications and Biomarker diagnostics, Worldwide Commercial Lead Yervoy® from the US and Vice President, specialty business …Lire la suite

Gary Littlejohn

From 2008 to 2015, Mr. Littlejohn held the position of CEO and then of advisor to the Chairman and Board Member of the Arab National Investment Company, also known as ANB Invest, in Riyadh, a subsidiary of Arab National Bank. Previously, he was Managing Director of investment banking at Desjardins Securities in Montreal, a position …Lire la suite